NYSE : FMS
Fresenius Medical Care AG — Key statistics
Healthcare · Medical Care Facilities · Germany
Last price 23.13 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 12.27B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 12.10B |
| Enterprise Value | 24.30B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | May 22, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | n/a |
| Shares Outstanding | 266.11M |
| Shares Change (YoY) | -4.44% |
| Shares Change (QoQ) | -2.47% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 48.76% |
| Float | 197.75M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 12.07 |
| Forward PE | 10.84 |
| PS Ratio | 0.54 |
| Forward PS | 0.54 |
| PB Ratio | 0.78 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.01 |
| P/OCF Ratio | 3.79 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 22.61 |
| EV / Sales | 1.09 |
| EV / EBITDA | 7.79 |
| EV / EBIT | 10.64 |
| EV / FCF | 12.11 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.07 |
| Quick Ratio | 0.63 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | 3.27 |
| Debt / FCF | 6.27 |
| Interest Coverage | 5.20 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 8.52% |
| Return on Assets (ROA) | 3.98% |
| Return on Invested Capital (ROIC) | 6.64% |
| Return on Capital Employed (ROCE) | 8.26% |
| Weighted Average Cost of Capital (WACC) | 5.66% |
| Revenue Per Employee | $206,991 |
| Profits Per Employee | $9,992 |
| Employee Count | 107,226 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 6.61 |
Taxes
| Measure | Value |
|---|
| Income Tax | 359.02M |
| Effective Tax Rate | 20.93% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.81 |
| 52-Week Price Change | -15.78% |
| 50-Day Moving Average | 22.37 |
| 200-Day Moving Average | 22.88 |
| Relative Strength Index (RSI) | 53.73 |
| Average Volume (20 Days) | 1,333,161 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.96M |
| Short Previous Month | 2.75M |
| Short % of Shares Out | 0.20% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.08 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 22.19B |
| Gross Profit | 5.85B |
| Operating Income | 2.28B |
| Pretax Income | 1.72B |
| Net Income | 1.07B |
| EBITDA | 3.11B |
| EBIT | 2.28B |
| Earnings Per Share (EPS) | $1.87 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.21B |
| Total Debt | 12.54B |
| Net Cash | -11.33B |
| Net Cash Per Share | -$42.57 |
| Equity (Book Value) | 15.46B |
| Book Value Per Share | 53.91 |
| Working Capital | 584.65M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 3.17B |
| Capital Expenditures | -1.17B |
| Depreciation & Amortization | 816.36M |
| Net Borrowing | -539.91M |
| Free Cash Flow | 2.00B |
| FCF Per Share | $7.51 |
Margins
| Measure | Value |
|---|
| Gross Margin | 26.36% |
| Operating Margin | 10.26% |
| Pretax Margin | 7.73% |
| Profit Margin | 4.83% |
| EBITDA Margin | 14.01% |
| EBIT Margin | 10.26% |
| FCF Margin | 9.19% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.61 |
| Dividend Yield | 2.68% |
| Dividend Growth (YoY) | 6.38% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 32.49% |
| FCF Payout Ratio | 8.10% |
| Buyback Yield | 4.44% |
| Shareholder Yield | 7.14% |
| Earnings Yield | 8.28% |
| FCF Yield | 16.63% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $23.77 |
| Price Target Difference | 5.08% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 2.19% |
| EPS Growth Forecast (3Y) | 4.84% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Dec 4, 2012 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.78 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |